Position in ANRO
as of Jun 30, 2026
· filed Sep 2, 2026
Position Value
$686,140
+$45,460 QoQ
Shares Held
26,000
-8.8% QoQ
Ownership
0.066%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#60
of 114 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANRO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Allianz Asset Management GmbH holds $783,743,061 across 80 Biotechnology names. ANRO ranks #46 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
380,618 | $237,330,545 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
545,071 | $131,345,757 | |
| 3 | MRNA |
Moderna, Inc.
|
984,497 | $68,944,324 | |
| 4 | EXEL |
Exelixis, Inc.
|
666,268 | $36,251,640 | |
| 5 | INCY |
Incyte Corp
|
229,921 | $26,063,844 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
418,602 | $23,952,406 | |
| 7 | APGE |
Apogee Therapeutics, Inc.
|
177,000 | $23,493,210 | |
| 8 | FTRE |
Fortrea Holdings Inc.
|
1,141,537 | $19,862,743 |
All Filings in ANRO
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $686,140 | 26,000 | Shares | Defined | 2026-09-02 | |
| 2026-03-31 | $640,680 | 28,500 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $765,400 | 43,000 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $148,740 | 37,000 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $81,400 | 37,000 | Shares | Defined | 2025-07-28 | |
| 2025-03-31 | $79,920 | 37,000 | Shares | Defined | 2025-05-05 | |
| 2024-12-31 | $262,683 | 62,100 | Shares | Defined | 2025-02-03 | |
| 2024-09-30 | $422,136 | 36,900 | Shares | Defined | 2024-11-13 | |
| No filing history on record for this holder in this stock. | ||||||